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Edited by Lukas HuberAbstract Here we studied the mechanism of cell sensitization to
oxidative stress by analyzing the gene expression proﬁle of ser-
um-deprived astrocytes. Exposure to serum-free medium (i) sen-
sitized astrocytes to oxidative stress, (ii) reduced the expression
of several genes involved in protection against oxidative stress,
including heme oxygenase 1, and (iii) changed the expression
of several genes involved in the control of cell survival, including
the stress-regulated protein p8. Our results support that serum
deprivation sensitizes astrocytes to oxidative stress via a p38
mitogen-activated protein kinase-dependent p8 upregulation that
leads in turn to decreased heme oxygenase 1 expression.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Oxidative stress is one of the major causes of cell damage in
the central nervous system. Thus, several neurodegenerative dis-
eases such as Parkinson’s, Huntington’s and Alzheimer’s dis-
eases and brain injury states such as ischemia, hypoxia and
trauma have been shown to be associated to increased oxidative
injury [1–5]. Accordingly, the study of the mechanisms involved
in the generation of reactive oxygen species as well as of the cyto-
protective antioxidant pathways may allow the identiﬁcation of
molecular targets for the design of neuroprotective therapeutic
strategies. Astrocytes are a central component of the brain de-
fense against oxidative stress [6,7]. For example, astrocytes pro-
vide neuronswith glutathione precursors and ascorbate, serve as
a sink for nitric oxide, and produce chemical mediators that can
contribute to delayed neural death, thereby protecting neurons
from oxidative injury [8]. It is therefore of especial interest to
investigate the mechanisms that regulate the sensitivity of astro-
cytes to oxidative damage in these cells. We had previously
shown that incubation of astrocytes in serum-free medium ren-
ders these cells more sensitive to H2O2 [9]. In the present study
we characterize the gene expression proﬁle of serum-deprived
astrocytes as a means to investigate the molecular mechanisms
involved in the sensitization to oxidative stress.Abbreviations: p38 MAPK, p38 mitogen-activated protein kinase; HO-
1, heme oxygenase 1; NQO-1, NAD(P)H dehydrogenase quinone 1;
SOD-2, superoxide dismutase 2
*Corresponding author. Fax: +34 913944672.
E-mail address: gvd@bbm1.ucm.es (G. Velasco).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.01.0842. Materials and methods
2.1. Cell culture and viability
Cortical astrocytes were prepared from postnatal (24 h-old) Wistar
rats and cultured in a mixture of Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM) and Ham’s F12 medium (1:1, v/v) supplemented with
0.5% (w/v) glucose, 5 mg/ml streptomycin, 5 U/ml penicillin and 10%
fetal calf serum as previously described [10]. After 21 days, serum
deprivation was performed by removing the serum-containing med-
ium and replacing it by a chemically deﬁned serum-free medium con-
sisting of Dulbecco’s modiﬁed Eagle’s medium (DMEM) and Ham’s
F12 medium (1:1, v/v) supplemented with 5 mg/ml streptomycin,
5 lg/ml insulin, 50 lg/ml transferrin, 20 nM progesterone, 50 lM
putrescine and 30 nM sodium selenite. Cell viability was determined
by the MTT test.2.2. Analysis of gene expression in serum-deprived astrocytes
Total RNA was isolated with the RNeasy Protect kit (Qiagen, Hil-
den, Germany) including a DNase digestion step using the RNase-free
DNase kit (Qiagen) from astrocytes deprived of serum for 24 h (con-
trol), 48 or 96 h. RNA was ampliﬁed and labeled using the low-input
RNA ampliﬁcation kit (Agilent technologies, Palo Alto, CA) and
hybridized on a 22 k rat array (Agilent technologies) (see Supplemen-
tary MIAME). To avoid the inﬂuence of replacement with fresh ser-
um-free medium on gene expression and protein activation ([11], see
below), RNA extracted from cells incubated for 24 h in serum-free
medium was selected as a reference.2.3. Reverse transcription-PCR analysis
RNA was isolated as described above. cDNA was obtained with
Transcriptor (Roche, Basel, Switzerland). Primers were used to amplify
mRNA for rat p8 [5 0-GCCACCTTGCCACCAACAGCC-3 0 and
5 0-TCAGCGCCAGGCCTTTTTCC-3 0 (239 bp product)], rat heme
oxygenase 1 (HO-1) [5 0-TGCTCGCATGAACACTCTG-3 0 and 5 0-
TCCTCTGTCAGCAGTGCCT-3 0 (123 bp product)], rat superoxide
dismutase 2 (SOD-2) [5 0-GGCCAAGGGAGATGTTACAA-3 0 and
5 0-GCTTGATAGCCTCCAGCAAC-30 (149 bp product)], rat
NAD(P)H dehydrogenase quinone 1 (NQO-1) [5 0-GGCTGGTTT-
GAGAGAGTG-3 0 and 5 0-GTCGGCTGGAATGGACTTG-30 (460
bp product)] and rat GAPDH [5 0-GGGAAGCTCACTGGCATGGC-
CTTCC-3 0 and 5 0-CATGTGGGCCATGAGGTCCACCAC-3 0 (322
bp product)]. PCR reactions were performed using the following
parameters: 95 C for 5 min, 94C for 30 s, 57 C (p8, SOD-2, NQO-
1, HO-1 and GAPDH) for 30 s, and 72 C for 1 min, followed by a ﬁnal
extension step at 72 C for 5 min. The number of cycles was adjusted to
allow detection in the linear range.2.4. Real-time quantitative PCR
cDNA was obtained with Transcriptor (Roche). Taqman probes
were obtained from Applied Biosystems (Foster City, California).
Ampliﬁcations were run in a 7700 Real-Time PCR System (Applied
Biosystems). Each value was adjusted by using GAPDH mRNA levels
as reference.2.5. Western blot
Western blot analysis was performed as described [9]. Anti-HO-1
and anti a-tubulin antibodies (Sigma Chemical Co., St. Louis, MO) were
used.blished by Elsevier B.V. All rights reserved.
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Conﬂuent astrocytes were transfected with siRNA duplexes using
Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA). Eighteen hours
after transfection medium was replaced by fresh serum-free medium.
Experiments were performed after 5 days incubation in serum-free
medium.2.7. RNA interference
Double-stranded RNA duplexes corresponding to rat p8 [(5 0-
GGACGUACCAAGAGAGAAGCU) or a pool of four diﬀerent siR-
NAs targeted to rat p8] and a non-targeted control (5 0-UUCUCC-
GAACGUGUCACGU-3 0) were purchased from Dharmacon
(Lafayette, Colorado) and Eurogentec (Liege, Belgium), respectively.
2.8. Statistics
Results shown represent means ± SD. Statistical analysis was per-
formed by ANOVA with a post hoc analysis by the Student–Neu-
man–Keuls test.3. Results and discussion
3.1. Gene expression proﬁle of serum-deprived astrocytes
Serum deprivation sensitizes astrocytes to oxidative stress [9]
(Fig. 1A). In order to investigate the molecular mechanisms
responsible for this sensitization, we used DNA arrays to ana-
lyze the changes in gene expression that occur during exposure
of primary astrocytes to serum-free medium. As shown in Sup-
plementary Table 1, serum deprivation for 2 and 4 days re-
duced mRNA levels of NQO-1, SOD-2 and HO-1
(Supplementary Table 1; Fig. 1B, C and D), three proteins di-
rectly involved in protection against oxidative stress [12–14]. In
addition, changes in the expression of a large number of genes,
including transcription factors that participate in the control of
cell fate, genes related with apoptosis as well as cytokines and
cytokine-related genes, occurred in both 2 and 4-day serum-de-
prived astrocytes (Supplementary Table 1).
3.2. The stress protein p8 is involved in sensitization to oxidative
stress
One of the genes that were upregulated during serum-depri-
vation was the stress protein p8 (Supplementary Table 1;
Fig. 2A). p8 belongs to the family of HMG-I/Y transcription
factors and was originally described as a gene induced during
the acute phase of pancreatitis [15]. In addition, p8 has been
shown to be upregulated in response to several stresses
[11,15–17]. We therefore tested whether p8 plays a role in the
sensitization to oxidative stress in our model of H2O2-induced
apoptosis [9]. Reduction of p8 mRNA levels by using p8-selec-
tive siRNA prevented the H2O2-induced decrease of cell viabil-
ity in serum deprived astrocytes (Fig. 2B), indicating that p8Fig. 1. Serum deprivation reduces the expression of oxidative stress
protective genes. Panel A: Astrocytes were incubated with or without
serum for 5 days, further transferred to serum-free medium and treated
for 18 h with vehicle or the indicated concentrations of H2O2, and cell
viability was determined. Results correspond to four diﬀerent exper-
iments and are expressed as the percentage of viable cells relative to the
corresponding vehicle-treated cells. *Signiﬁcantly diﬀerent (P < 0.05)
from the corresponding H2O2-treated cells incubated in complete
medium. Panel B: Cells were incubated in serum-free medium for the
indicated times, total RNA was isolated and gene expression using
DNA array analysis was performed. Results correspond to three
independent experiments and are expressed as the fold induction
relative to expression at day 1 (only the values of the indicated genes
are shown). Panel C: Cells were incubated in serum-free medium for
the indicated times, total RNA was isolated and RT-PCR for the
indicated genes was performed. A representative experiment of 3 is
shown. NQO-1, NAD(P)H dehydrogenase quinone 1; SOD-2, super-
oxide dismutase 2; HO-1, heme-oxygenase 1. Panel D: Cells were
incubated in serum-free medium for the indicated times, cell lysates
were obtained and protein levels of HO-1 were analyzed by Western
blot. A representative experiment of 2 is shown.
b
Fig. 2. p8 upregulation is required for sensitization of serum-deprived astrocytes to oxidative stress. Panel A: Astrocytes were incubated in serum-
free medium for the indicated times, total RNA was isolated and real-time quantitative PCR (upper panel) or RT-PCR (lower panel) analysis of p8
and GAPDH expression was performed. Results correspond to three experiments and are expressed as fold induction relative to day 1 (upper panel).
A representative experiment of 3 is shown (lower panel). **Signiﬁcantly diﬀerent (P < 0.01) from p8 expression at day 1. Panel B: Astrocytes were
transfected with control (siRNA C), p8-selective (siRNA p8-1) or a pool of four diﬀerent p8-selective (siRNA p8-2) siRNAs, incubated in serum-free
medium for 5 days, and total RNA was isolated (upper panel) or cells were treated with vehicle or 100 lM H2O2 for 18 h and cell viability was
determined (lower panel). Results correspond to four diﬀerent experiments and are expressed as the percentage of viable cells relative to the
corresponding vehicle-treated cells. Signiﬁcantly diﬀerent *(P < 0.05) from vehicle-treated siRNA C-transfected cells and ##(P < 0.01) from H2O2-
treated siRNA C-transfected cells (lower panel). No signiﬁcant diﬀerences of cell viability were observed between vehicle-treated cells transfected with
siRNA C, siRNA p8-1 or siRNA p8-2. p8 levels were determined by real-time quantitative PCR. Results correspond to three diﬀerent experiments
and are expressed as the mean-fold change in gene expression relative to siRNA C transfected cells. Signiﬁcantly diﬀerent **(P < 0.01) from siRNA
C-transfected cells (upper panel). Panel C: Astrocytes were transfected with control or p8-selective siRNA (siRNA p8-1), incubated in serum-free
medium for 5 days, total RNA was isolated, and p8, HO-1, SOD-2, NQO-1 or GAPDHmRNA levels were determined by RT-PCR. A representative
experiment of 3 is shown. Values of gene expression as determined by real-time quantitative PCR in that experiment (expressed as fold-change
relative to siRNA C-transfected cells) are shown in parentheses.
A. Carracedo et al. / FEBS Letters 580 (2006) 1571–1575 1573upregulation is required for astrocyte sensitization to oxidative
stress.
HO-1 plays an important role in protection against oxidative
stress [14,18–20] and their levels are modulated in response to
several oxidative insults [18,21,22] including serum deprivation
(see above). Since it has been postulated that p8 acts as a co-
transcription factor to regulate gene expression [23–25], we
next investigated whether p8 participates in the regulation of
HO-1 levels. As shown in Fig. 2C, selective knock-down of
p8 mRNA levels prevented the decrease in HO-1 mRNA levels
observed in serum-deprived astrocytes (Fig. 2C). By contrast,
the levels of NQO-1 and SOD-2 did not change by p8 knock
down (Fig. 2C). These results suggest that p8 is involved in
sensitization of astrocytes to oxidative stress via down-regula-
tion of HO-1.
3.3. p38 MAPK is involved in sensitization to oxidative stress
through the control of p8 levels
We have previously observed that the stress-activated ki-
nase p38 mitogen-activated protein kinase (p38 MAPK) [26]
is stimulated in astrocytes upon serum deprivation [9]. There-
fore, we tested whether the activation of this kinase plays a
role in the sensitization of serum-deprived astrocytes to oxi-
dative stress. Incubation with the selective p38 MAPK inhib-
itor PD169316 prevented (i) the H2O2-induced decrease ofcell viability in serum-deprived astrocytes (Fig. 3A), (ii) the
serum deprivation-induced increase in p8 mRNA levels
(Fig. 3B), and (iii) the serum deprivation-induced decrease
of HO-1 levels (Fig. 3C). These results are in line with previ-
ous observations that had implicated p38 MAPK in the reg-
ulation of p8 expression in other cellular models [27], and
indicate that p38 MAPK is involved in sensitization of astro-
cytes to oxidative stress via p8 upregulation (Fig. 3D).
3.4. Concluding remarks
Data presented here show that serum deprivation leads to
important changes in the gene expression proﬁle of astrocytes.
In particular, our results indicate that the decrease in the
expression of several genes encoding antioxidant enzymes par-
ticipates in the sensitization of these cells to oxidative stress. In
addition, we show that p38 MAPK and the stress-regulated
protein p8 play an important regulatory role in this eﬀect
(see Fig. 3D). To the best of our knowledge, these ﬁndings
show for the ﬁrst time the involvement of p8 in the response
to oxidative stress and speciﬁcally in the regulation of HO-1
expression. Although further research is still necessary to com-
pletely understand the mechanisms involved in this eﬀect, our
results suggest that this pathway may be a target for pharma-
cological strategies aimed at minimizing brain damage caused
by oxidative stress.
Fig. 3. p38 MAPK is involved in sensitization to oxidative stress via p8 and HO-1 regulation. Panel A: Astrocytes were incubated in serum-free
medium for 5 days in the presence of vehicle (control) or 0.4 lM PD169316 (PD p38), further treated with vehicle or 100 lMH2O2 for 18 h, and cell
viability was determined. Results correspond to four diﬀerent experiments and are expressed as the percentage of viable cells relative to the
corresponding vehicle-treated cells. Signiﬁcantly diﬀerent **(P < 0.01) from vehicle-treated control cells and ##(P < 0.01) from H2O2-treated control
cells. Panel B: Astrocytes were incubated in serum-free medium in the presence of vehicle or 0.4 lM PD169616 (PD p38), total RNA was isolated at
the indicated times and p8 mRNA levels were determined using real-time quantitative PCR. Results correspond to three diﬀerent experiments and are
expressed as the number of fold induction relative to p8 expression of vehicle-treated cells at day 1. **Signiﬁcantly diﬀerent (P < 0.01) from vehicle-
treated cells at each time-point. Panel C: Astrocytes were incubated in serum-free medium for 5 days in the presence of vehicle or 0.4 lM PD169316,
total RNA was isolated and p8, HO-1 and GAPDH mRNA levels were determined by using RT-PCR. A representative experiment of 3 is shown.
Panel D: Proposed model of the mechanism involved in serum deprivation-induced sensitization of astrocytes to oxidative stress.
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